APA (7th ed.) Citation

A, R., A, S., AE, S., WC, C., HA, d. S., GL, D. T., . . . PK, W. (2024). Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: A randomised, double-blind, active-controlled, international clinical trial. Lancet (London, England), 404(10462), 1536. https://doi.org/10.1016/S0140-6736(24)01744-6

Chicago Style (17th ed.) Citation

A, Rodgers, et al. "Efficacy and Safety of a Novel Low-dose Triple Single-pill Combination of Telmisartan, Amlodipine and Indapamide, Compared with Dual Combinations for Treatment of Hypertension: A Randomised, Double-blind, Active-controlled, International Clinical Trial." Lancet (London, England) 404, no. 10462 (2024): 1536. https://doi.org/10.1016/S0140-6736(24)01744-6.

MLA (9th ed.) Citation

A, Rodgers, et al. "Efficacy and Safety of a Novel Low-dose Triple Single-pill Combination of Telmisartan, Amlodipine and Indapamide, Compared with Dual Combinations for Treatment of Hypertension: A Randomised, Double-blind, Active-controlled, International Clinical Trial." Lancet (London, England), vol. 404, no. 10462, 2024, p. 1536, https://doi.org/10.1016/S0140-6736(24)01744-6.